These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12089534)
1. First biotech drug to treat psoriasis. Mitchell P Nat Biotechnol; 2002 Jul; 20(7):640-1. PubMed ID: 12089534 [No Abstract] [Full Text] [Related]
2. Alefacept: potential new therapy for patients with moderate-to-severe psoriasis. Shukla VK Issues Emerg Health Technol; 2003 Apr; (45):1-4. PubMed ID: 12680422 [TBL] [Abstract][Full Text] [Related]
3. The 'heartbreak of psoriasis' has met its match! Morrow T Manag Care; 2003 Jun; 12(6):13, 17-8. PubMed ID: 12854254 [No Abstract] [Full Text] [Related]
5. First biologic treatment approved for psoriasis. FDA Consum; 2003; 37(3):4. PubMed ID: 12793376 [No Abstract] [Full Text] [Related]
6. New psoriasis drug tackles T cells. Health News; 2003 Apr; 9(4):8-9. PubMed ID: 12710397 [No Abstract] [Full Text] [Related]
7. Alefacept for psoriasis and psoriatic arthritis. Gottlieb AB Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv58-60. PubMed ID: 16239390 [TBL] [Abstract][Full Text] [Related]
8. Alefacept in the treatment of psoriatic nail disease: a proof of concept study. Parrish CA; Sobera JO; Robbins CM; Cantrell WC; Desmond RA; Elewski BE J Drugs Dermatol; 2006 Apr; 5(4):339-40. PubMed ID: 16673801 [TBL] [Abstract][Full Text] [Related]
9. Treatment of palmoplantar psoriasis with intramuscular alefacept. Myers W; Christiansen L; Gottlieb AB J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S127-9. PubMed ID: 16021161 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis. Menter A; Cather JC; Baker D; Farber HF; Lebwohl M; Darif M J Am Acad Dermatol; 2006 Jan; 54(1):61-3. PubMed ID: 16384756 [TBL] [Abstract][Full Text] [Related]
11. Possibilities of using alefacept in the treatment of psoriasis. Pietrzak A; Chodorowska G; Bartkowiak-Emeryk M; Pietrzak B; Urban J; Juszkiewicz-Borowiec M; Miturska R Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):311-3. PubMed ID: 15323211 [TBL] [Abstract][Full Text] [Related]
14. Treatment of plaque psoriasis. Hanauer L N Engl J Med; 2001 Dec; 345(25):1854; author reply 1854-5. PubMed ID: 11803920 [No Abstract] [Full Text] [Related]
15. Differential clinical response to alefacept in combination with methotrexate in two patients with refractory palmar psoriasis. Jacobi A; Schuler G; Hertl M Br J Dermatol; 2007 Jan; 156(1):178-80. PubMed ID: 17199593 [No Abstract] [Full Text] [Related]
16. The application of the patent laws to the drug approval process. Coggio BD; Cerrito FD Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669 [No Abstract] [Full Text] [Related]
17. Alefacept treatment for chronic plaque psoriasis. Dunn LK; Feldman SR Skin Therapy Lett; 2010 Apr; 15(4):1-3. PubMed ID: 20361167 [TBL] [Abstract][Full Text] [Related]
18. Triazure and public drug policies. Shubin S Perspect Biol Med; 1979; 22(2 Pt 1):185-204. PubMed ID: 582335 [No Abstract] [Full Text] [Related]
19. Alefacept for the treatment of psoriasis and other dermatologic diseases. Strober BE; Menon K Dermatol Ther; 2007; 20(4):270-6. PubMed ID: 17970892 [TBL] [Abstract][Full Text] [Related]
20. Etanercept for the treatment of psoriasis and psoriatic arthritis. Gottlieb AB Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]